Arja Kaipainen

14.9k total citations · 6 hit papers
57 papers, 10.0k citations indexed

About

Arja Kaipainen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Arja Kaipainen has authored 57 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Arja Kaipainen's work include Angiogenesis and VEGF in Cancer (21 papers), Lymphatic System and Diseases (10 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Arja Kaipainen is often cited by papers focused on Angiogenesis and VEGF in Cancer (21 papers), Lymphatic System and Diseases (10 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Arja Kaipainen collaborates with scholars based in United States, Finland and Sweden. Arja Kaipainen's co-authors include Kari Alitalo, Vladimir Joukov, Olli Saksela, Katri Pajusola, Eola Kukk, Tuija Mustonen, Jaana Korhonen, Michael Jeltsch, Dipak Panigrahy and Nisse Kalkkinen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Arja Kaipainen

56 papers receiving 9.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

1996 1.4k citations Vladimir Joukov, Katri Pajusola et al. profile →
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

1995 1.1k citations Arja Kaipainen, Jaana Korhonen et al. profile →
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

1997 1.0k citations Arja Kaipainen, Vladimir Joukov et al. profile →
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

1996 593 citations Katri Pajusola, Arja Kaipainen et al. profile →
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.

1994 574 citations Arja Kaipainen, Kari Alitalo et al. profile →
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

1996 505 citations Athina Lymboussaki, Arja Kaipainen et al. profile →

Peers

Countries citing papers authored by Arja Kaipainen

Since Specialization

Citations

This map shows the geographic impact of Arja Kaipainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arja Kaipainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arja Kaipainen more than expected).

Fields of papers citing papers by Arja Kaipainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arja Kaipainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arja Kaipainen. The network helps show where Arja Kaipainen may publish in the future.

Co-authorship network of co-authors of Arja Kaipainen

This figure shows the co-authorship network connecting the top 25 collaborators of Arja Kaipainen. A scholar is included among the top collaborators of Arja Kaipainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arja Kaipainen. Arja Kaipainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress 2020 ·Cell Reports ·Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, Navonil De Sarkar, Arja Kaipainen, Gavin Ha, Roman Gulati, Lisa S. Ang, Payel Chatterjee, Jared M. Lucas, Colin C. Pritchard, Gail P. Risbridger, John T. Isaacs, Bruce Montgomery, Colm Morrissey, Eva Corey, Peter S. Nelson	163
2	Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer 2019 ·Clinical Cancer Research ·Alexandra Corella, (unknown), Ilsa M. Coleman, Jared M. Lucas, Arja Kaipainen, Holly M. Nguyen, (unknown), Lisha G. Brown, Lawrence D. True, John K. Lee, David MacPherson, Paul Nghiem, Roman Gulati, Colm Morrissey, Eva Corey, Peter S. Nelson	32
3	Molecular determinants of response to high-dose androgen therapy in prostate cancer 2019 ·JCI Insight ·Michael D. Nyquist, Alexandra Corella, (unknown), Ilsa M. Coleman, Arja Kaipainen, Daniel A. Kuppers, Jared M. Lucas, Patrick J. Paddison, Stephen R. Plymate, Peter S. Nelson, Elahe A. Mostaghel	18
4	Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer 2017 ·Clinical Cancer Research ·Elahe A. Mostaghel, Eunpi Cho, Ailin Zhang, Mohammad Alyamani, Arja Kaipainen, (unknown), Brett T. Marck, Nima Sharifi, Jonathan L. Wright, Roman Gulati, Lawrence D. True, Massimo Loda, Alvin M. Matsumoto, Daniel Tamae, (unknown), Steven P. Balk, Philip W. Kantoff, Peter S. Nelson, Mary-Ellen Taplin, Bruce Montgomery	31
5	Inhibition of tumor angiogenesis by oral etoposide 2010 ·Experimental and Therapeutic Medicine ·Dipak Panigrahy, Arja Kaipainen, Catherine Butterfield, Deviney M. Chaponis, Andrea Laforme, Judah Folkman, Mark W. Kieran	34
6	Cytochrome P450-derived eicosanoids: the neglected pathway in cancer 2010 ·Cancer and Metastasis Reviews ·Dipak Panigrahy, Arja Kaipainen, Emily R. Greene, Sui Huang	142
7	Sucrose octasulfate regulates fibroblast growth factor‐2 binding, transport, and activity: Potential for regulation of tumor growth 2007 ·Journal of Cellular Physiology ·Michael Fannon, Kimberly Forsten‐Williams, Matthew A. Nugent, (unknown), Chia Lin Chu, (unknown), Dipak Panigrahy, Arja Kaipainen, Carmen Barnes, (unknown), Yuen Shing	8
8	PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth 2007 ·PLoS ONE ·Arja Kaipainen, Mark W. Kieran, Sui Huang, Catherine Butterfield, Diane R. Bielenberg, Gustavo Mostoslavsky, Richard C. Mulligan, Judah Folkman, Dipak Panigrahy	74
9	Trehalose lyophilized platelets for wound healing 2007 ·Wound Repair and Regeneration ·Giorgio Pietramaggiori, Arja Kaipainen, David H. Ho, Cindy Orser, (unknown), Alan S. Rudolph, Dennis P. Orgill	35
10	PPARγ as a therapeutic target for tumor angiogenesis and metastasis 2005 ·Cancer Biology & Therapy ·Dipak Panigrahy, Sui Huang, Mark W. Kieran, Arja Kaipainen	118
11	The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study 2005 ·Journal of Pediatric Surgery ·Harry Applebaum, Mark W. Kieran, Timothy P. Cripe, Cheryl M. Coffin, Margaret H. Collins, Arja Kaipainen, Andrea Laforme, Robert C. Shamberger	66
12	Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype 2004 ·Journal of Clinical Investigation ·Diane R. Bielenberg, Yasuhiro Hida, Akio Shimizu, Arja Kaipainen, Michael Kreuter, (unknown), Michael Klagsbrun	19
13	Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype 2004 ·Journal of Clinical Investigation ·Diane R. Bielenberg, Yasuhiro Hida, Akio Shimizu, Arja Kaipainen, Michael Kreuter, (unknown), Michael Klagsbrun	235
14	PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis 2002 ·Journal of Clinical Investigation ·Dipak Panigrahy, Samuel Singer, Lucy Q. Shen, Catherine Butterfield, Deborah A. Freedman, Emy J. Chen, Marsha A. Moses, Susan Kilroy, Stefan Duensing, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Lynn Hlatky, Philip Hahnfeldt, Judah Folkman, Arja Kaipainen	240
15	PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis 2002 ·Journal of Clinical Investigation ·Dipak Panigrahy, Samuel Singer, Lucy Q. Shen, Catherine Butterfield, Deborah A. Freedman, Emy J. Chen, Marsha A. Moses, Susan Kilroy, Stefan Duensing, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Lynn Hlatky, Philip Hahnfeldt, Judah Folkman, Arja Kaipainen	308
16	Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature 1999 ·Developmental Dynamics ·Karin Aase, Athina Lymboussaki, Arja Kaipainen, Birgitta Olofsson, Kari Alitalo, Ulf Eriksson	81
17	Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors 1998 ·American Journal Of Pathology ·Athina Lymboussaki, Taina A. Partanen, Birgitta Olofsson, Judith Thomas-Crusells, Christopher D.�M. Fletcher, Robert M.W. de Waal, Arja Kaipainen, Kari Alitalo	181
18	Expression of Vascular Endothelial Growth Factor and Placenta Growth Factor in Human Placenta1 1997 ·Biology of Reproduction ·Piia Vuorela, E Hatva, Athina Lymboussaki, Arja Kaipainen, Vladimir Joukov, M. Graziella Persico, Kari Alitalo, Erja Halmesmäki	212
19	The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. 1993 ·The Journal of Experimental Medicine ·Arja Kaipainen, Jaana Korhonen, Katri Pajusola, Olga Aprelikova, M. Graziella Persico, Bruce I. Terman, Kari Alitalo	207
20	A recurrent chondromyxoid fibroma with chromosome aberrations ins(5;2)(q13;p21p25) and 2p deletion: A case report 1993 ·Cancer Genetics and Cytogenetics ·Maija Tarkkanen, Tom Böhling, (unknown), Erkki Karaharju, Arja Kaipainen, Jadwiga A. Szymańska, Inkeri Elomaa, Sakari Knuutila	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact